Bosentan Does Not Affect Renal Resistive Index in Scleroderma/Systemic Sclerosis Patients

Author:

Di Poi EmmaORCID,Colussi GianLucaORCID,Bertoni MartinaORCID,Giovannini IvanORCID,Tolusso BarbaraORCID,Ferraccioli Gian FrancoORCID,Gremese ElisaORCID,De Vita SalvatoreORCID,Romano GiulioORCID

Abstract

<b><i>Introduction:</i></b> If properly evaluated, chronic kidney disease can be found in up to 50% of patients with systemic sclerosis (SSc). The renal resistive index (RRI) is a marker of intrarenal vascular resistance and can predict SSc-associated vasculopathy. This study aimed to determine the impact of bosentan, a nonselective endothelin-1 receptor antagonist, on RRI and kidney function in SSc patients with recurrent digital ulcers. <b><i>Methods:</i></b> Twenty-one patients (age 57 ± 9 years, 19 females) were recruited in a 16-week prospective open-label uncontrolled study. Standardized procedures were used to measure general clinical and laboratory characteristics, systolic, diastolic, and mean arterial pressure (MAP), pulse pressure (PP), diastolic to systolic blood pressure (D/S) ratio, and urinary endothelin-1 levels. The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation was used to calculate kidney function as an estimated glomerular filtration rate (eGFR). RRI was measured by Doppler ultrasound as the average of three samplings of intrarenal blood flow in different kidney regions of both kidneys. Patients with secondary causes of kidney disease or kidney diseases associated with albuminuria were excluded. <b><i>Results:</i></b> Bosentan treatment for 16 weeks did not change RRI (0.731 ± 0.049–0.730 ± 0.054, <i>p</i> = 0.925), but increased urine endothelin-1 to creatinine ratio (0.27 ± 0.15–0.49 ± 0.57 pg/mg, <i>p</i> = 0.032) and reduced MAP (123 ± 10–101 ± 11 mm Hg, <i>p</i> &lt; 0.001), PP (76 ± 11–68 ± 10 mm Hg, <i>p</i> = 0.003), D/S ratio (0.563 ± 0.044–0.538 ± 0.031, <i>p</i> = 0.006), and eGFR (92 ± 20–84 ± 24 mL/min/1.73 m<sup>2</sup>, <i>p</i> = 0.003). <b><i>Discussion/Conclusion:</i></b> In conclusion, in patients with SSc complicated by digital ulcers and normal to mildly diminished kidney function, bosentan had no effect on intrarenal hemodynamics, but reduced blood pressure levels and kidney function.

Publisher

S. Karger AG

Subject

Cardiology and Cardiovascular Medicine,Nephrology,Cardiology and Cardiovascular Medicine,Nephrology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3